Literature DB >> 23513011

Physiological response to the 6-minute walk test in chronic heart failure patients versus healthy control subjects.

Gaël Deboeck1, Alain Van Muylem2, Jean Luc Vachiéry2, Robert Naeije3.   

Abstract

BACKGROUND: The distance walked in 6 minutes (6MWD) has been reported to be linearly related to peak oxygen uptake (VO2) in cardiac diseases and in lung diseases. In these patients, the VO2 during a 6-min walk test (walkVO2) has been found to be nearly equivalent to peakVO2, but with a lower respiratory exchange ratio (RER). Whether these observations translate to the less functionally impaired patients or healthy control subjects is not exactly known.
METHODS: Thirty-two healthy control subjects and 15 chronic heart failure (CHF) patients performed a 6-min walk test and a maximal cardiopulmonary exercise test (CPET) both with measurements of gas exchange.
RESULTS: The 6MWD and peakVO2 were linearly correlated, but with an increased slope appearing above 532 m. In CHF patients, walkVO2 was similar to peakVO2, but with lower heart rate and ventilation than measured at peak exercise. In healthy control subjects, VO2, ventilation and heart rate were lower during the 6-min walk than at maximal exercise but higher than at the anaerobic threshold. The RER during the 6-min walk remained <1 in both groups.
CONCLUSIONS: Above 500 m, 6MWD becomes less sensitive to any increase in peakVO2. Furthermore, CHF patients and healthy control subjects exercise respectively at maximal and high VO2, but below the anaerobic threshold (as assessed by a CPET) during the 6-min walk test. © The European Society of Cardiology 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  6-min walk test; chronic heart failure; exercise physiology; exercise testing; healthy subjects; oxygen consumption

Mesh:

Year:  2013        PMID: 23513011     DOI: 10.1177/2047487313482283

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  8 in total

Review 1.  Six-Minute Walk Test for Assessing Physical Functional Capacity in Chronic Heart Failure.

Authors:  Huiyun Du; Parichat Wonggom; Jintana Tongpeth; Robyn A Clark
Journal:  Curr Heart Fail Rep       Date:  2017-06

2.  [Heart or lung? : Diagnostics and management of unclear exertional dyspnea].

Authors:  H Wilkens; M Held
Journal:  Herz       Date:  2018-09       Impact factor: 1.443

3.  Comparison of the six-minute walk test with a cycle-based cardiopulmonary exercise test in people following curative intent treatment for non-small cell lung cancer.

Authors:  Vinicius Cavalheri; Sue Jenkins; Nola Cecins; Kevin Gain; Kylie Hill
Journal:  Chron Respir Dis       Date:  2016-02-11       Impact factor: 2.444

Review 4.  6-minute walking test: a useful tool in the management of heart failure patients.

Authors:  Sophia Giannitsi; Mara Bougiakli; Aris Bechlioulis; Anna Kotsia; Lampros K Michalis; Katerina K Naka
Journal:  Ther Adv Cardiovasc Dis       Date:  2019 Jan-Dec

5.  The Chinese (Mandarin) instructions of the 6-minute walk test: A validation study.

Authors:  Vivian Z Tan; Meredith Q Lee; Daryl L Wong; Katherin S Huang; Melissa Y Chan; Clement C Yan; Meredith T Yeung
Journal:  Hong Kong Physiother J       Date:  2021-01-13

6.  Maximal cardiac output determines 6 minutes walking distance in pulmonary hypertension.

Authors:  Gaël Deboeck; Dolores Taboada; Guy Hagan; Carmen Treacy; Kathy Page; Karen Sheares; Robert Naeije; Joanna Pepke-Zaba
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

7.  Efficacy of cardiac rehabilitation after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Authors:  Shigefumi Fukui; Takeshi Ogo; Hiroshi Takaki; Jin Ueda; Akihiro Tsuji; Yoshiaki Morita; Reon Kumasaka; Tetsuo Arakawa; Michio Nakanishi; Tetsuya Fukuda; Satoshi Yasuda; Hisao Ogawa; Norifumi Nakanishi; Yoichi Goto
Journal:  Heart       Date:  2016-05-24       Impact factor: 5.994

8.  Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose.

Authors:  Janet D Pierce; Diane E Mahoney; John B Hiebert; Amanda R Thimmesch; Francisco J Diaz; Carol Smith; Qiuhua Shen; Dinesh Pal Mudaranthakam; Richard L Clancy
Journal:  BMC Cardiovasc Disord       Date:  2018-04-02       Impact factor: 2.298

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.